Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 Infection
NCT ID: NCT05336110
Last Updated: 2022-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5189 participants
OBSERVATIONAL
2022-03-14
2022-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT04961489
NOsocomial Dissemination Risk of SARS-Cov2
NCT04339881
Measures for the Prevention of Surgical Site Infection
NCT03551561
Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19
NCT04386070
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT06285838
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The deployment of vaccination against SARS-CoV-2 from 2021 led to a modification of these recommendations in June 2021 suggesting local adaptations of this delay if epidemic developments appear. Today, the evolutions of the pandemic make these recommendations obsolete and impose the updating of the data produced during the first epidemic wave of 2020. Among these evolutions, the two most important are the existence of a large vaccination coverage on the one hand and the emergence of variants of lesser severity on the other hand
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with a positive preoperative SARS-CoV-2 test
Patient with a positive preoperative SARS-CoV-2 test
Postponing surgery
Postponing surgery for patients with Sars-cov-2 infection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Postponing surgery
Postponing surgery for patients with Sars-cov-2 infection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgery performed in the operating room under general or locoregional anesthesia.
* Result of the preoperative SARS-COV-2 diagnostic test available on the day of the procedure or within 48 hours of the surgery.
* Emergency or scheduled surgery
* All surgical indications will be eligible with the exception of certain surgeries
Exclusion Criteria
* Pregnant patient
* Surgery or an intervention performed outside the operating room
* Patient operated under sedation alone,
* Patient under guardianship or curatorship
* Patient without social protection
* Patient previously included in this study
* Patient without preoperative COVID-19 status on day of surgery and not diagnosable within 48 postoperative hours
* Patient whose immediate postoperative follow-up is planned in a structure other than those where the inclusion was made
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société Française d'Anesthésie et de Réanimation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marc GARNIER, MD
Role: PRINCIPAL_INVESTIGATOR
HOPITAL TENON - PARIS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'Amiens
Amiens, , France
CHU d'Angers
Angers, , France
CH Victor Dupouy
Argenteuil, , France
Cinique Belharra
Bayonne, , France
CH de Blois
Blois, , France
CHU de Brest - la Cavale Blanche
Brest, , France
HIA Clermont Tonnerre
Brest, , France
CHU de Caen - Anesthésie Réanimation
Caen, , France
CHU de Caen
Caen, , France
CH Charleville Mézière - CH Intercommunal Nord Ardennes
Charleville-Mézières, , France
AP-HP - Hôpital Beaujon
Clamart, , France
Hôpital Antoine Béclère, Clamart
Clamart, , France
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, , France
CHU Grenoble-Alpes
La Tronche, , France
CHU de Lille - hôpital Claude Huriez
Lille, , France
Hôpital E. Herriot - Hospices Civils de Lyon
Lyon, , France
CHU La Timone - Marseille
Marseille, , France
Hôpital Nord, Marseille
Marseille, , France
Clinique du Sport de Bordeaux Mérignac
Mérignac, , France
CHU de Nantes
Nantes, , France
Hopital Tenon
Paris, , France
AP-H P - Hôpital Lariboisière
Paris, , France
AP-HP - Groupe Hospitalier Pitié-Salpêtrière (bloc central)
Paris, , France
AP-HP - Groupe Hospitalier Pitié-Salpêtrière
Paris, , France
AP-HP - Hôpital Bichat
Paris, , France
AP-HP - Hôpital Saint-Antoine
Paris, , France
AP-HP - Hôpital Saint-Louis
Paris, , France
Clinique Drouot Rémusa
Paris, , France
Clinique Saint Jean de Dieu
Paris, , France
Centre Henri Becquerel
Rouen, , France
CHU Sud Réunion (Saint-Pierre)
Saint-Pierre, , France
CHU Strasbourg- Hautepierre
Strasbourg, , France
CHU de Toulouse -Hôpital Purpan
Toulouse, , France
CHU de Toulouse -Hôpital rangueil
Toulouse, , France
Clinique Pasteur, Toulouse
Toulouse, , France
CHRU de Tours - Hôpital Trousseau
Tours, , France
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, , France
Centre Gustave Roussy
Villejuif, , France
Polyclinique de Villeneuve Saint Georges
Villeneuve-Saint-Georges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-A00228-35
Identifier Type: OTHER
Identifier Source: secondary_id
DROMIS-22 / 2022-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.